Status:
RECRUITING
Observational Pharmaco-Epidemiology Research & Analysis
Lead Sponsor:
Epividian
Conditions:
Chronic Disease
HIV/AIDS
Eligibility:
All Genders
Brief Summary
Greater advances are needed in two separate but related areas in healthcare: 1) the Clinical Decision Support Systems that complement the EHR use in support of routine patient care, population managem...
Detailed Description
Objectives of OPERA 1. To research numerous chronic diseases (HIV, HCV, HBV currently and IBD and RA in the near future, with others as identified for further consideration) utilizing the OPERA® long...
Eligibility Criteria
Inclusion
- Patients who are treated in the practices who enroll and participate in the study
- Patients whose treatment is documented in the practice's electronic health record system
Exclusion
- Patients who opt out of OPERA
Key Trial Info
Start Date :
December 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2035
Estimated Enrollment :
2000000 Patients enrolled
Trial Details
Trial ID
NCT03813862
Start Date
December 1 2013
End Date
November 1 2035
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Epividian
Durham, North Carolina, United States, 27703